The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes (Q38602464)

4 September 2017

The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes (English)

1 reference

4 September 2017

1 reference

1 reference

1 reference

1

Tamara S Hannon

1 reference

4 September 2017

Silva A Arslanian

2

1 reference

PubMed ID

26448515

4 September 2017

language of work or name

English

0 references

publication date

8 October 2015

1 reference

Annals of the New York Academy of Sciences

4 September 2017

1 reference

4 September 2017

1353

1 reference

4 September 2017

113-137

1 reference

The pancreas in human type 1 diabetes

4 September 2017

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Type 1 diabetes mellitus: etiology, presentation, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Type 2 diabetes mellitus in youth: the complete picture to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetes prevalence and diagnosis in US states: analysis of health surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Changing Prevalence of Overweight Children and Adolescents at Onset of Insulin-Treated Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetic retinopathy in the SEARCH for Diabetes in Youth Cohort: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Presence of diabetes risk factors in a large U.S. eighth-grade cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

A school-based intervention for diabetes risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The global spread of type 2 diabetes mellitus in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Autoimmunity to islet proteins in children diagnosed with new-onset diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetic autoimmune markers in children and adolescents with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obesity and youth diabetes: distinguishing characteristics between islet cell antibody positive vs. negative patients over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Risk factors for type 2 diabetes in a sixth- grade multiracial cohort: the HEALTHY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Management of type 2 diabetes: new and future developments in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Beta-cell function across the spectrum of glucose tolerance in obese youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Characterization of insulin secretion and resistance in type 2 diabetes of adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Basal alpha-cell up-regulation in obese insulin-resistant adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Decreased beta-cell function in overweight Latino children with impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Predictors of changes in glucose tolerance status in obese youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Type 2 diabetes in children: clinical aspects and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Progressive deterioration of β-cell function in obese youth with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Glycemic control in youth with type 2 diabetes declines as early as two years after diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Evaluation of glucose intolerance in adolescents relative to adults with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Parental transmission of type 2 diabetes: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Association of common genetic variants in the MAP4K4 locus with prediabetic traits in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Co-occurrence of risk alleles in or near genes modulating insulin secretion predisposes obese youth to prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Genetics of type 2 diabetes and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The genetics of type 2 diabetes: what have we learned from GWAS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Genetics and type 2 diabetes in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The predisposition to obesity and diabetes in offspring of diabetic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The early origins of later obesity: pathways and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Ethnic differences in insulin action in obese African-American and Latino adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Type 2 diabetes in youth: are there racial differences in β-cell responsiveness relative to insulin sensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Longitudinal study on pubertal insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Pubertal changes of insulin sensitivity, acute insulin response, and β-cell function in overweight Latino youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Correlates of depressive symptoms in urban youth at risk for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Psychological symptoms and insulin sensitivity in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Metabolic correlates with obstructive sleep apnea in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Sleep architecture and glucose and insulin homeostasis in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Sleep duration and insulin resistance in healthy black and white adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Morning blood pressure is associated with sleep quality in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Utility of A1C for diabetes screening in the 1999 2004 NHANES population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Are the ADA hemoglobin A(1c) criteria relevant for the diagnosis of type 2 diabetes in youth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Obesity, increased linear growth, and risk of type 1 diabetes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Ketoacidosis-onset type 2 diabetes in Japanese. Association with the widespread distribution of soft drinks and vending machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetic ketoacidosis among obese African-American adolescents with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Treatment effects on measures of body composition in the TODAY clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Standards of medical care in diabetes--2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Secondary failure of metformin monotherapy in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Epidemiology of diabetic retinopathy and macular oedema: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetic neuropathy and foot complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Acute and chronic complications of type 2 diabetes mellitus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The SEARCH for Diabetes in Youth study: rationale, findings, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Management of type 2 diabetes mellitus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Low-grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

High burden of kidney disease in youth-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The role of blood pressure variability in the development of nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Early signs of cardiovascular disease in youth with obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Earlier onset of complications in youth with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Differing effects of metformin on glycemic control by race-ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

The TODAY study: an NIH perspective on its implications for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

A "spoonful of sugar" and the realities of diabetes prevention!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12939

21 January 2018

Identifiers

DOI

10.1111/NYAS.12939

1 reference

4 September 2017

1 reference

PubMed ID

26448515